Brain-skin connection: Is atopic dermatitis associated with demonstrable basal ganglia dysfunction?

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 33, Issue 1, 2009, Pages 164-165

  Usui, Chie ^a   Hatta, Kotaro ^a   Kikuchi, Yuko ^a   Arai, Heii ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ATOPIC DERMATITIS; BASAL GANGLION; BECK DEPRESSION INVENTORY; BRAIN BLOOD FLOW; BRAIN REGION; CASE REPORT; CINGULATE GYRUS; DEPRESSION; DISEASE SEVERITY; HAMILTON SCALE; HUMAN; INSULA; LETTER; MALE; PREFRONTAL CORTEX; SOMATOSENSORY CORTEX; SUBSTANTIA NIGRA; SUICIDAL IDEATION; SYMPTOMATOLOGY; THALAMUS; VISUAL ANALOG SCALE;

ADULT; BASAL GANGLIA; DEPRESSION; DERMATITIS, ATOPIC; HUMANS; MALE; SUICIDE;

EID: 58149382417     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2008.11.006     Document Type: Letter

References (13)

1. Altschuler E.L., and Kast R.E. Using histamine (H1) antagonists, in particular atypical antipsychotics, to treat anemia of chronic disease via interleukin-6 suppression. Med Hypotheses 65 1 (2005) 65-67
2. Bringhurst C., Waterston K., Schofield O., Benjamin K., and Rees J.L. Measurement of itch using actigraphy in pediatric and adult populations. J Am Acad Dermatol 51 6 (2004) 893-898
3. Chida Y., Steptoe A., Hirakawa N., Sudo N., and Kubo C. The effects of psychological intervention on atopic dermatitis. A systematic review and meta-analysis. Int Arch Allergy Immunol 144 1 (2007) 1-9
4. Chida Y., Hamer M., and Steptoe A. A bidirectional relationship between psychosocial factors and atopic disorders: a systematic review and meta-analysis. Psychosom Med 70 1 (2008) 102-116
5. Dannlowski U., Baune B.T., Boeckermann I., Domschke K., Evers S.T., Arolt V., Hetzel G., and Rothermundt M. Adjunctive antidepressant treatment with quetiapine in agitated depression: positive effects on symptom reduction, psychopathology and remission rates. Hum Psychopharmacol 23 7 (2008) 587-593
6. Elenkov I.J. Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being. Neurochem Int 52 1-2 (2008) 40-51
7. Gonul A.S., K.M., Oguz A., Tutus A., and Izgi H.B. Regional cerebral blood flow changes associated with quetiapine treatment in schizophrenic patients without extrapyramidal symptoms. Eur Neuropsychopharmcol 2 suppl 4 (2003) 2
8. Ikoma A., Steinhoff M., Stander S., Yosipovitch G., and Schmelz M. The neurobiology of itch. Nat Rev 7 7 (2006) 535-547
9. Martin J. Neuroanatomy, Text and Atlas. 3rd ed (2003), McGraw-Hill, New York
10. Michaud M., Soucy J.P., Chabli A., Lavigne G., and Montplaisir J. SPECT imaging of striatal pre- and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep. J Neurol 249 2 (2002) 164-170
11. Schneider G., Stander S., Burgmer M., Driesch G., Heuft G., and Weckesser M. Significant differences in central imaging of histamine-induced itch between atopic dermatitis and healthy subjects. Eur J Pain (London, England) 12 7 (2008) 834-841
12. Takeuchi R., Yonekura Y., Matsuda H., and Konishi J. Usefulness of a three-dimensional stereotaxic ROI template on anatomically standardised 99mTc-ECD SPET. Eur J Nucl Med Mol Imaging 29 3 (2002) 331-341
13. Timonen M., Jokelainen J., Hakko H., Silvennoinen-Kassinen S., Meyer-Rochow V.B., Herva A., et al. Atopy and depression: results from the Northern Finland 1966 Birth Cohort Study. Mol Psychiatry 8 8 (2003) 738-744